Senior insider sale
SVP Chief Financial Officer at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$112.7K
4.63K shares
What this filing means
VAIRAVAN LATHA plans to sell 4.63K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $112.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001628280-26-033587
Officer· SVP Chief Financial Officer
Since Feb 2026
4.63K
Shares to sell
$112.7K
Approx. market value
435.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
NA
5/1/2026
435.00Total acquired435.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2026 | Restricted Stock Vesting NA | 435.00 | — |
| Total | 435.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.34K
Market value
$31.7K
5/4/2026
—Completed
Units to sell
2.85K
Market value
$71.8K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
435.00
Market value
$9.2K
5/11/2026
Total
Units
4.63K
Value
$112.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/4/2026 | 1.34K | $31.7K | — | Completed |
3/2/2026 | 2.85K | $71.8K | — | Completed |
| Planned — Approximate Date | ||||
5/11/2026 | 435.00 | $9.2K | NASDAQ | Planned |
| Total | 4.63K | $112.7K | ||